Protagonist Therapeutics Inc (PTGX)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	434,433	60,000	26,581	24,582	28,628
Revenue	US$ in thousands	434,433	60,000	26,581	27,357	28,628
Gross profit margin		100.00%	100.00%	100.00%	89.86%	100.00%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $434,433K ÷ $434,433K
= 100.00%

Protagonist Therapeutics Inc's gross profit margin has shown a consistent performance over the past years based on the provided data. The margin was at 100.00% in December 31, 2020, indicating that the company was able to retain all revenue after accounting for the cost of goods sold. However, there was a slight decline in the following year, with the gross profit margin falling to 89.86% as of December 31, 2021. This reduction could suggest an increase in the cost of goods sold relative to revenue generated.

Subsequently, the company managed to improve its gross profit margin, returning to 100.00% for the last three years: December 31, 2022, December 31, 2023, and December 31, 2024. This rebound demonstrates the firm's ability to effectively manage production costs and maintain a strong pricing strategy to preserve a higher percentage of revenue as gross profit.

In conclusion, despite a transient decrease in 2021, Protagonist Therapeutics Inc has showcased stability in its gross profit margin in recent years, ultimately returning to the maximum level of 100.00%. This consistency indicates the company's efficiency in controlling production costs and optimizing revenue generation.